Agenus Doses First COVID-19 Patient with iNKT Cell Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. TJX
10. DE

Go back to Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
AGENUS (NASDAQ: AGEN) Delayed: 7.79 -0.47 (5.69%)
Previous Close $8.26    52 Week High $7.49 
Open $8.22    52 Week Low $2.61 
Day High $8.25    P/E N/A 
Day Low $7.72    EPS $-1.10 
Volume 554,891